Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Celgene: Blockbuster Biotech Bet
Nov 10, 2008 10:23 AM
- A List of Best Performing Stocks Year to Date
May 26, 2008 09:21 PM
- Will Synta Break A 30 Year Old Record?
Apr 27, 2008 04:04 PM
- Biotechs Coming Alive:
Apr 15, 2008 02:16 AM
- Media Digest for 4/14
Apr 14, 2008 10:33 AM
- Media Digest for 4/11
Apr 11, 2008 09:59 AM
- ASIA MARKETS: Tokyo Lifts Region As Shares Of Exporters Climb
Apr 11, 2008 05:22 AM
- What to do with the Biotech sector?
Apr 11, 2008 01:50 AM
- Analyst Comments: XL Capital, Sinopec, SCOR Group, Cleveland-Cliff, Dell, Millennium Pharma, Theravance
Apr 11, 2008 01:40 AM
- Observations and Stocks for Friday
Apr 11, 2008 12:50 AM
- Takeda Completes Acquisition of Millennium
May 14, 2008 01:21 PM
- Takeda Completes Subsequent Offering Period for Shares of Millennium Pharmaceuticals, Inc.
May 14, 2008 07:01 AM
- New Analyst Reports for GILEAD SCIENCES INC, ISIS PHARMACEUTICALS INC, CURIS INC, and MILLENNIUM PHARMACEUTICALS INC
May 09, 2008 02:06 PM
- Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period
May 09, 2008 02:22 AM
- Mergent, Inc. Announces Changes to the HealthShares(TM) Composite, Enabling Technologies, Autoimmune-Inflammation, Cancer, Cardiology and Neuroscience Indexes
May 06, 2008 04:01 PM
- Standard & Poor's Announces Changes to U.S. Indices
May 05, 2008 05:43 PM
- Takeda and Millennium Announce Early Termination of Hart-Scott-Rodino Waiting Period
Apr 29, 2008 07:01 AM
- Market Pulse Breaking News Alert for Tuesday, April 15, 2008: NCEN - Nacel Energy Deploys Advanced Wind Assessment Systems at Blue Creek and Channing Flats Power Projects!
Apr 15, 2008 08:30 AM
- Takeda Commences Cash Tender Offer for all Outstanding Shares of Millennium
Apr 11, 2008 04:20 PM
- BellwetherReport.com Free Analyst Review for MLNM, VMED, FCSX, and APOG
Apr 10, 2008 10:42 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
MLNM
|
Compare to S&P
|
| YTD |
66.69 %
|
76.23 %
|
| 4 Weeks |
1.88 %
|
-1.30 %
|
| 12 Weeks |
81.73 %
|
75.46 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 1,400.00 %
|
|
EPS Growth in Last Year: 333.33 %
|
|
Sales Growth in Last Quarter: -23.04 %
|
|
Sales Growth in Last Quarter: 25.94 %
|
|
|
